Phase I study using weekly Taxol (T) and gemcitabine (G) in patients with advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
De Pas, T
De Braud, F
Sessa, C
Nole, F
Minchella, I
Catania, C
Goldhirsch, A
机构：
[1] EIO, Milano, Italy
[2] HS Giovanni, Bellinzona, Switzerland
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
375
引用
收藏
页码：98 / 99
页数：2
相关论文
共 50 条
  • [31] Gemcitabine(GEM) in advanced non small cell lung cancer (NSCLC) of elderly. A phase II study
    Pasquini, E
    Tassinari, D
    Nicolini, M
    Gianni, L
    Oliverio, G
    Tononi, A
    Papi, M
    Drudi, G
    Panzini, I
    Ravaioll, A
    ANNALS OF ONCOLOGY, 1998, 9 : 32 - 32
  • [32] Phase I dose-escalation study of vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small-cell lung cancer (NSCLC)
    Teixeira, L.
    Descourt, R.
    Moro-Sibilot, D.
    Misset, J. L.
    Gachard, E.
    Rizvi, S.
    Roben, E.
    Zalcman, G.
    EJC SUPPLEMENTS, 2009, 7 (02): : 554 - 554
  • [33] Vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small cell lung cancer (NSCLC): A Phase I dose-escalation study
    Tredaniel, J.
    Descourt, R.
    Moro-Sibilot, D.
    Misset, J.
    Gachard, E.
    Garcia-Vargas, J.
    Roben, E.
    Zalcman, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] A phase I/II study of pembrolizumab (P) with gemcitabine (G) in patients (Pts) with previously-treated advanced non-small cell lung cancer (NSCLC): Phase I safety results
    Sanborn, Rachel E.
    Duffy, Regan M.
    Fisher, Brenda K.
    Perlewitz, Kelly Shea
    Redmond, William L.
    Koguchi, Yoshinobu
    Fox, Bernard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Phase I/II study of weekly docetaxel in patients with previously treated non-small cell lung cancer (NSCLC).
    Hirata, T
    Kawashita, F
    Ogawa, E
    Masago, K
    Kato, M
    Takada, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 676S - 676S
  • [36] Gemcitabine combined with cisplatin in non-small cell lung cancer (NSCLC): A phase I/II study
    Steward, WP
    Dunlop, DJ
    Cameron, C
    Talbot, DC
    Kleisbauer, JL
    Thomas, P
    Guerin, JC
    Perol, M
    Sanson, C
    Dabouis, G
    Lacroix, H
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1081 - 1081
  • [37] Weekly paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC).
    Nakagawa, K
    Fukuoka, M
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 704S - 704S
  • [38] Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer
    Okuda, Kentaro
    Hirose, Takashi
    Ishida, Hiroo
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Ando, Kohichi
    Shirai, Takao
    Ohnishi, Tsukasa
    Horichi, Naoya
    Ohmori, Tohru
    Adachi, Mitsuru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (05) : 829 - 835
  • [39] Phase I study of irinotecan and gemcitabine in previously untreated, patients with advanced non-small cell lung cancer
    Takatani, Hiroshi
    Soda, Hiroshi
    Nakamura, Yoichi
    Kinoshita, Akitoshi
    Fukuda, Masaaki
    Nagashima, Seiji
    Fukuda, Minoru
    Soejima, Yoshifumi
    Nakano, Hirofumi
    Oka, Mikio
    Kohno, Shigeru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (05) : 353 - 357
  • [40] Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer
    Kentaro Okuda
    Takashi Hirose
    Hiroo Ishida
    Sojiro Kusumoto
    Tomohide Sugiyama
    Kohichi Ando
    Takao Shirai
    Tsukasa Ohnishi
    Naoya Horichi
    Tohru Ohmori
    Mitsuru Adachi
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 829 - 835
12345